![trans-N-[1-(2-fluorophenyl)-1H-pyrazol-3-yl]-1'-oxospiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxamide,CAS No. 328232-95-7.](https://public.whmall.com/system/0/chemical/image/2007/09/04/1188888888-386183_C22H19FN4O3.png "trans-N-[1-(2-fluorophenyl)-1H-pyrazol-3-yl]-1'-oxospiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxamide,CAS No. 328232-95-7.")
trans-N-[1-(2-fluorophenyl)-1H-pyrazol-3-yl]-1'-oxospiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxamide CAS No.328232-95-7 / Cat No.EBD386183
trans-N-[1-(2-fluorophenyl)-1H-pyrazol-3-yl]-1'-oxospiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxamide
trans-N-[1-(2-fluorophenyl)-1H-pyrazol-3-yl]-3-oxo-3H-spiro[6-aza-2-benzofuran-1,1'-cyclohexane]-4'-carboxamide
trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro[6-azaisobenzofuran-1(3H), 1'-cyclohexane]-4'-carboxamide
trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro[6-azaisobenzofuran-1(3H),1'-cyclohexane]-4'-carboxamide
NMR Spectrum
Prediction： Table 2. Carbon-13 cross-polarization magic-angle spinning (CPMAS) nuclear magnetic resonance rNMR): Compound I Crystal Form CPosition (PPM) Intensity (relative)176.3 40.0 EPO 172.7 38.5165.8 55.0152.3 30.9 147.8 89.8 143.1 23.4 133.5 53.6127.1 100.0123.2 25.1119.4 60.9101.5 30.7 100.0 28.388.7 66.9 87.3 65.873.3 9.1 36.2 51.732.8 35.530.4 38.2 27.0 27.7 22.8 33.0
1H NMR
13C NMR
